Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine) |
Stages | Early Stage, Seed |
Investing | United Kingdom |
Investment Range | $7,000,000 - $30,000,000 |
Medicxi Ventures (MEH-DEE-CHEE) is a life sciences-focused investment firm, originally created at Index Ventures, a leading international venture capital firm with offices in London, San Francisco, Geneva, and St. Helier (Jersey). Francesco De Rubertis joined Index at the end of 1997 to launch the firm's life sciences practice and was joined in the following years by three partners: Kevin Johnson, Michèle Ollier and David Grainger. Over the years, Index Ventures raised a total of twelve funds, with separate life sciences and technology investment teams.